Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VHY | Ann: Exit Statement | 29/07/25 | 0 | 134 | |||
|
|||||||
VHY | Ann: FATCA and CRS Tax Residency Certification Reminder | 24/07/25 | 0 | 130 | |||
|
|||||||
VHY | Ann: Outstanding ETF Securities and Fund Flows Announcement | 07/07/25 | 0 | 254 | |||
|
|||||||
VHY | Ann: Estimated Distribution Announcement | 03/07/25 | 10 | 3.0K | |||
|
|||||||
VHY | Ann: Distribution Tax Estimates | 02/07/25 | 0 | 230 | |||
|
|||||||
VHY | Ann: DRP Issue Price Announcement | 02/07/25 | 0 | 182 | |||
|
|||||||
VHY | Ann: Final Distribution Announcement | 02/07/25 | 0 | 247 | |||
|
|||||||
VHY | Ann: Updated Estimated Distribution Announcement | 01/07/25 | 0 | 189 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |